Freeport-McMoRan Inc. FCX
Verdict: Strong sell. Fair value $45.23 against a price of $54.41 on 6 Jan 2026, 17% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Net Income fell by 47% from 2022 to 2023 ($3.47B to $1.85B) while revenue and OCF remained stable.....
Main risks
- Severe Profitability Decline: Net income has collapsed from $4.31B in 2021 to $1.89B in 2024, highlighting extreme earnings volatility and sensitivity to commodity prices.
- Negative Returns on Investment: A deeply negative estimated 3-year ROIIC of -37% suggests that significant recent capital expenditures have coincided with a sharp fall in operating profit, indicating value-destructive capital allocation, likely driven by a cyclical downturn.
- High Capital Intensity & Volatile FCF: The business requires massive CapEx ($4.73B TTM), leading to volatile Free Cash Flow (ranging from $5.6B in 2021 to $0.46B in 2023), creating uncertainty for shareholder returns.
- Net Income fell by 47% from 2022 to 2023 ($3.47B to $1.85B) while revenue and OCF remained stable....
- Valuation prices in optimistic scenario (limited margin for error)
- Net Income fell by 47% from 2022 to 2023 ($3.47B to $1.85B) while revenue and OCF remained stable. This suggests large non-cash charges are obscuring core profitability. The gap between OCF ($7.16B) and Net Income ($1.89B) in 2024 is substantial ($5.27B), making GAAP earnings a poor proxy for economic performance.